Skip to main content
Loading

Advances In High-Throughput Screening Technologies & Their Application In Rna-Targeted Drug Discover

26 Jun 2025
Oligonucleotide Discovery
  • Next-Generation Screening Platforms for RNA Targets, exploring AI-driven screening, RNA-targeted small molecule discovery, and high-throughput sequencing approaches to accelerate drug development
  • Leveraging structure-based design, ribonucleoprotein (RNP) assays, and automated screening technologies to improve specificity and binding efficiencyBridging the Gap from Screening to Clinical Translation
  • Overcoming validation, scalability, and regulatory challenges to ensure high-confidence hits progress successfully into preclinical and clinical stages.
Industry Expert
Timothy Keefe, Director CMC Analytical Development and QC - CuriRx